| Date | Cabinet / DG | Subject | Attending |
|---|---|---|---|
| 2014-12-18 | Cabinet of Commissioner Carlos Moedas | European industry’s perspective on the future of EU research and innovation policy | Carlos Moedas (Commissioner) |
| 2014-12-19 | Cabinet of Commissioner Carlos Moedas | Innovative Medecines Initiative / Ebola crisis | Giulia Del Brenna (Cabinet member) |
| 2015-01-23 | Cabinet of Vice-President Neven Mimica | EFPIA engagement in developing countries | Nils Behrndt (Cabinet member) |
| 2015-01-26 | Cabinet of Vice-President Neven Mimica | Anti-biotic resistance within development policy | Paolo Berizzi (Cabinet member) |
| 2015-02-10 |
| Cabinet of Vice-President Cecilia Malmström |
| TTIP |
| Maria Asenius (Cabinet member),Miguel Ceballos Baron (Cabinet member) |
| 2015-02-10 | Cabinet of Commissioner Carlos Moedas | Science and innovation | Antonio Lowndes Marques De Araujo Vicente (Cabinet member) |
| 2015-02-25 | Cabinet of Vice-President Cecilia Malmström | Trade negotiations and health | Cécile Billaux (Cabinet member) |
| 2015-04-22 | Trade | Trade relations with US and China | Jean-Luc Demarty (Director-General) |
| 2015-05-28 | Cabinet of Commissioner Vytenis Andriukaitis | Developments of pharmaceutical industry | Arunas Vinciunas (Cabinet member) |
| 2015-11-19 | Cabinet of Vice-President Cecilia Malmström | TTIP | Maria Asenius (Cabinet member),Miguel Ceballos Baron (Cabinet member) |
| 2015-11-25 | Health and Food Safety | AMR | Xavier Prats Monné (Director-General) |
| 2016-02-23 | Cabinet of Vice-President Neven Mimica | Access to health care and pharmaceuticals in developing countries | Nils Behrndt (Cabinet member) |
| 2016-02-24 | Günther Oettinger | Big Data, ehealth | Günther Oettinger (Commissioner) |
| 2016-02-24 | Cabinet of Commissioner Vytenis Andriukaitis | Access to Medicines, HTA, AMR | Annika Nowak (Cabinet member),Vytenis Andriukaitis (Commissioner) |
| 2016-02-24 | Cabinet of Vice-President Cecilia Malmström | TTIP, CETA, affordable medicines | Cecilia Malmström (Commissioner) |
| 2016-06-03 | Cabinet of Commissioner Vytenis Andriukaitis | AMR, Situation in Ukraine | Annika Nowak (Cabinet member),Vytenis Andriukaitis (Commissioner) |
| 2016-06-15 | Cabinet of Commissioner Vytenis Andriukaitis | HTA, AMR, Access to innovative medicines | Annika Nowak (Cabinet member),Vytenis Andriukaitis (Commissioner) |
| 2016-10-07 | Cabinet of Commissioner Věra Jourová | GDPR | Kevin O'Connell (Cabinet member) |
| 2016-12-07 | Cabinet of Commissioner Carlos Moedas | Meeting with EPFIA'S President, IMI/Innovation Policy | Carlos Moedas (Commissioner),Giulia Del Brenna (Cabinet member) |
| 2017-01-31 | Cabinet of Commissioner Vytenis Andriukaitis | Non Communicable diseases | Annika Nowak (Cabinet member) |
| 2017-04-24 | Cabinet of Commissioner Vytenis Andriukaitis | Follow-up to COUNCIL conclusions: Impact of the incentives on innovation, availability and accessibility of medicinal products | Annika Nowak (Cabinet member) |
| 2017-06-29 | Cabinet of Vice-President Cecilia Malmström | Turkey - in breach of rules; Canada - some concerns around implementing legislation. | Christian Burgsmueller (Cabinet member),Maria Asenius (Cabinet member) |
| 2017-10-27 | Task Force for Relations with the United Kingdom | Meeting with the Task Force for the Preparation and Conduct of the Negotiations with the United Kingdom under Article 50 TEU | Michel Barnier (Head of Task Force) |
| 2017-11-29 | Cabinet of Commissioner Vytenis Andriukaitis | Pharmaceutical incentives, antimicrobial resistance | Annika Nowak (Cabinet member),Vytenis Andriukaitis (Commissioner) |
| 2017-12-15 | Cabinet of Commissioner Vytenis Andriukaitis | AMR; Pharma | Annika Nowak (Cabinet member) |
| 2018-01-12 | Health and Food Safety | Discussion on AMR | Xavier Prats Monné (Director-General) |
| 2018-01-17 | Cabinet of Vice-President Neven Mimica | Role of pharmaceutical industry in development cooperation | Irena Andrassy (Cabinet member),Nils Behrndt (Cabinet member) |
| 2018-01-30 | Cabinet of Commissioner Elżbieta Bieńkowska | Exchange of views on current topics | Elżbieta Bieńkowska (Commissioner),Fabrice Comptour (Cabinet member) |
| 2018-02-08 | Cabinet of Vice-President Cecilia Malmström | Possible change of EU patent legislation | Maria Asenius (Cabinet member),Nele Eichhorn (Cabinet member) |
| 2018-03-15 | Cabinet of Commissioner Tibor Navracsics | Research & Innovation policy | Patricia Reilly (Cabinet member) |
| 2018-03-19 | Cabinet of Vice-President Neven Mimica | Health in development cooperation | Nils Behrndt (Cabinet member) |
| 2018-03-21 | Cabinet of Vice-President Günther Oettinger | competitiveness of the life science industry in Europe | Michael Hager (Cabinet member) |
| 2018-04-19 | Cabinet of Vice-President Jyrki Katainen | Competitiveness of the European Pharmaceutical industry | Risto Artjoki (Cabinet member) |
| 2018-06-15 | Cabinet of Commissioner Vytenis Andriukaitis | HTA | Annika Nowak (Cabinet member),Vytenis Andriukaitis (Commissioner) |
| 2018-09-07 | Research and Innovation | Partnesrhips | Jean-Eric Paquet (Director-General) |
| 2018-12-03 | Health and Food Safety | courtesy visit | Anne Bucher (Director-General) |
| 2019-02-04 | Cabinet of Vice-President Jyrki Katainen | Supplementary Protection Certificate Manufacturing Waiver in Europe and EFPIA’s priorities in the context of the 2019 institutional changes | Jyrki Katainen (Vice-President) |
| 2019-04-23 | Research and Innovation | PPPs in health area | Jean-Eric Paquet (Director-General) |
| 2019-06-25 | Health and Food Safety | development of a High-level Forum on Healthcare; the Commission "outcomes" agenda; EU HTA Regulation proposal | Anne Bucher (Director-General) |
| 2019-06-26 | Cabinet of Commissioner Vytenis Andriukaitis | Access to medicines, shortages, medicines for rare diseases and children | Alina Timofte (Cabinet member),Arunas Vinciunas (Cabinet member),Vytenis Andriukaitis (Commissioner) |
| 2019-07-23 | Internal Market, Industry, Entrepreneurship and SMEs | Present their latest Manifesto and introduce the pharmaceutical companies position towards new Commission | Timo Pesonen (Acting Director-General) |
| 2019-08-29 | Cabinet of Vice-President Cecilia Malmström | Trade in the pharma sector | Miguel Ceballos Baron (Cabinet member) |
| 2019-08-29 | Cabinet of Commissioner Vytenis Andriukaitis | EFPIA position on the EU preliminary list of US products considered for countermeasures | Arunas Ribokas (Cabinet member) |
| 2020-01-23 | Cabinet of Commissioner Phil Hogan | presentation EFPIA's manifesto | Dermot Ryan (Cabinet member) |
| 2020-01-23 | Cabinet of Vice-President Dubravka Šuica | Integrated health solutions, active ageing, sustainability and quality of healthcare systems, long-term visions on healthcare | Astrid Dentler (Cabinet member) |
| 2020-01-23 | Cabinet of Commissioner Phil Hogan | presentation EFPIA's manifesto | Dermot Ryan (Cabinet member) |
| 2020-02-06 | Cabinet of Commissioner Elisa Ferreira | Medical innovation & Reform policies | Marlene Madsen (Cabinet member) |
| 2020-02-11 | Cabinet of Commissioner Stella Kyriakides | Pharmaceutical strategy | Olympia Neocleous (Cabinet member) |
| 2020-02-11 | Cabinet of Commissioner Janez Lenarčič | Health In humanitarian aid and in crisis management | Kasia Jurczak (Cabinet member) |
| 2020-02-28 | Cabinet of Commissioner Jutta Urpilainen | EFPIA requested a meeting to present their ongoing work | Renaud Savignat (Cabinet member) |